ContextVision had a great exhibition at the RSNA in the end of November in Chicago. Although we had great interest in our image enhancement solutions within all modalities, our 3D products for ultrasound and MRI caught a lot of attention at this year’s exhibition.

It has been a wonderful year 2012 and we are looking forward to a new year full of challenges, collaborations and other exciting happenings.

From all of us here at ContextVision, we wish you all a very Merry Christmas and a Happy New Year!

ContextVision had a good exhibition at Zdravookhraneniye last week in Moscow. Our X-ray product GOPView XR2PLUS including new add-on modules Exposure Index and Doctors Interface for parameter control caught a lot of attention and opened up for interesting discussions. In addition we also had a great interest for our image enhancement solutions for MRI, fluoroscopy and Mammography.

Откройте для себя новое измерение в улучшении качества изображения.
Передовые технологии ContextVision применяются уже сейчас, позволяя оптимизировать качество 2D/3D/4D изображений и улучшить точность постановки диагноза во всем мире.

ContextVision’s latest 2D/3D/4D technology is already improving image quality and clinical decision making world-wide. Come see us at Zdravookhraneniye and let us show you how you and your clients can benefit from this. Join us in Hall 2, Pavilion 2, Booth #22A34

AuntMinnieEurope.com
Written by AuntMinnieEurope.com staff writers.

Since 1983, ContextVision has pushed its image enhancement technology forward, delivering unparalleled diagnostic image quality to clinicians. At RSNA this year, ContextVision will demonstrate its cutting-edge software within ultrasound, X-ray, magnetic resonance imaging, mammography and more.

Откройте для себя новое измерение в улучшении качества изображения.
Когда изображение становится объемным, мы оптимизируем визуализацию нового измерения.

먁肝努좟緞獗藤퓻세減離품懶돨쏵嵐
흔쏟，緞獗攣꼍흙힛郭왕쇌돨랙嵐뱀돛，劍攣蕨乖쳬嵐君놔홍劤돨왕쇌郭똑。Contextvision離劤3D/4D세減

Read the article by ContextVision’s Director of Research & Development, Arto Järvinen, on DOTmed.